Literature DB >> 2874135

Cellular distribution of type I and type II receptors for transforming growth factor-beta.

S Cheifetz, B Like, J Massagué.   

Abstract

Affinity labeling of target cells for transforming growth factor-beta (TGF beta) by cross-linking with 125I-TGF beta via disuccinimidyl suberate or by the photoreactive analogue 4-azidobenzoyl-125I-TGF beta has revealed the presence of multiple TGF beta receptor forms. Two distinct types of TGF beta receptors can be distinguished based on structural analysis of the 125I-TGF beta-labeled species by peptide mapping. Type I TGF beta receptors include the 280-kilodalton labeled receptor form previously found to be the subunit of a disulfide-linked TGF beta receptor complex. (Massagué, J. (1985) J. Biol. Chem. 260, 7059-7066), as well as a 65-kDa labeled receptor form present in all cell lines examined, and a 130-140-kDa labeled receptor form detected only in 3T3-L1 cells. The 280-kDa form is the major TGF beta receptor species in most cell lines examined, but is apparently absent in rat skeletal muscle myoblasts. Type I TGF beta receptors bind TGF beta with an apparent Kd of 50-500 pM. Type II TGF beta receptors include an 85-kDa labeled receptor form present in all mammalian cells examined and a 110-kDa labeled receptor form present in chick embryo fibroblasts. Type II TGF beta receptors bind TGF beta with an apparent Kd of about 50 pM. Except for the 280-kDa type I TGF beta receptor form, none of the TGF beta receptor forms described here is found as part of a disulfide-linked receptor complex. All the TGF beta receptor forms described here behave as intrinsic membrane proteins exposed on the surface of intact cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2874135

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Parathyroid hormone modulates transforming growth factor beta activity and binding in osteoblast-enriched cell cultures from fetal rat parietal bone.

Authors:  M Centrella; T L McCarthy; E Canalis
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

2.  Type beta transforming growth factor is an inhibitor of myogenic differentiation.

Authors:  J Massagué; S Cheifetz; T Endo; B Nadal-Ginard
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

Review 3.  Growth factors in glioma angiogenesis: FGFs, PDGF, EGF, and TGFs.

Authors:  I F Dunn; O Heese; P M Black
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

4.  Inhibitory action of transforming growth factor beta on endothelial cells.

Authors:  G Müller; J Behrens; U Nussbaumer; P Böhlen; W Birchmeier
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

5.  Regulation of intestinal epithelial cell growth by transforming growth factor type beta.

Authors:  J A Barnard; R D Beauchamp; R J Coffey; H L Moses
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

6.  Transforming growth factor beta regulates thyroid growth. Role in the pathogenesis of nontoxic goiter.

Authors:  B Grubeck-Loebenstein; G Buchan; R Sadeghi; M Kissonerghis; M Londei; M Turner; K Pirich; R Roka; B Niederle; H Kassal
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

7.  Effect of transforming growth factor-beta on DNA synthesis by growth plate chondrocytes: modulation by factors present in serum.

Authors:  R J O'Keefe; J E Puzas; J S Brand; R N Rosier
Journal:  Calcif Tissue Int       Date:  1988-12       Impact factor: 4.333

8.  Mapping of the ligand binding domain of the transforming growth factor beta receptor type III by deletion mutagenesis.

Authors:  M C Pepin; M Beauchemin; J Plamondon; M D O'Connor-McCourt
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

9.  Vascular cells respond differentially to transforming growth factors beta 1 and beta 2 in vitro.

Authors:  J R Merwin; W Newman; L D Beall; A Tucker; J Madri
Journal:  Am J Pathol       Date:  1991-01       Impact factor: 4.307

10.  Transforming growth factor-beta increases steady state levels of type I procollagen and fibronectin messenger RNAs posttranscriptionally in cultured human dermal fibroblasts.

Authors:  R Raghow; A E Postlethwaite; J Keski-Oja; H L Moses; A H Kang
Journal:  J Clin Invest       Date:  1987-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.